4.4 Article

The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Health Care Sciences & Services

Exploring a novel method for optimising the implementation of a colorectal cancer risk prediction tool into primary care: a qualitative study

Shakira Milton et al.

Summary: This study explored the implementation of a colorectal cancer risk prediction tool (CRISP) in general practice using qualitative methods and identified successful and unsuccessful implementation strategies through an adaptive methodology over time. Co-design input was emphasized as crucial for sustainability of the intervention in other practices and with other risk tools.

IMPLEMENTATION SCIENCE (2022)

Article Medicine, General & Internal

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death

M. Bretthauer et al.

Summary: This randomized trial found that participants who were invited to undergo screening colonoscopy had a lower risk of colorectal cancer within 10 years.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Gastroenterology & Hepatology

Randomized Controlled Trial of Personalized Colorectal Cancer Risk Assessment vs Education to Promote Screening Uptake

Timothy Yen et al.

Summary: The study found that using CCRAT risk assessment did not increase participation or intent for colorectal cancer screening. Risk stratification may motivate individuals classified as higher CRC risk to complete screening, but inadvertently discourage screening among those not identified as higher risk.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Medicine, General & Internal

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Karina W. Davidson et al.

Summary: Colorectal cancer is a significant cause of cancer-related deaths, with high incidence in adults aged 65 to 74. Screening is recommended for adults aged 50 to 75 with substantial net benefit, for those aged 45 to 49 with moderate net benefit, and selective screening is advised for adults aged 76 to 85.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis

Chloe Thomas et al.

Summary: Population-based screening for colorectal cancer is effective and cost-effective. This study shows that risk-stratification using genetic and phenotypic risk factors could improve the effectiveness and cost-effectiveness of screening programs without requiring additional screening resources.

CANCER PREVENTION RESEARCH (2021)

Editorial Material Oncology

Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success

Erika A. Waters et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Editorial Material Medicine, General & Internal

Personalised and risk based cancer screening

Philippe Autier

BMJ-BRITISH MEDICAL JOURNAL (2019)

Editorial Material Medicine, General & Internal

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline

Lise M. Helsingen et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Medicine, General & Internal

Revised Australian national guidelines for colorectal cancer screening: family history

Mark A. Jenkins et al.

MEDICAL JOURNAL OF AUSTRALIA (2018)

Letter Medicine, General & Internal

Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014

Rebecca L. Siegel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medical Informatics

The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care

Jennifer G. Walker et al.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2017)

Review Oncology

Risk Prediction Models for Colorectal Cancer: A Systematic Review

Juliet A. Usher-Smith et al.

CANCER PREVENTION RESEARCH (2016)

Review Primary Health Care

Cancer Risk Assessment Tools in Primary Care: A Systematic Review of Randomized Controlled Trials

J. G. Walker et al.

ANNALS OF FAMILY MEDICINE (2015)

Review Oncology

Risk prediction tools for cancer in primary care

Juliet Usher-Smith et al.

BRITISH JOURNAL OF CANCER (2015)

Article Oncology

Screening Practices of Unaffected People at Familial Risk of Colorectal Cancer

Driss Ait Ouakrim et al.

CANCER PREVENTION RESEARCH (2012)

Article Gastroenterology & Hepatology

Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up

J. H. Scholefield et al.

Article Health Care Sciences & Services

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Kevin E. Thorpe et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)

Review Gastroenterology & Hepatology

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update

Paul Hewitson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Medicine, General & Internal

Developing and evaluating complex interventions: the new Medical Research Council guidance

Peter Craig et al.

BMJ-BRITISH MEDICAL JOURNAL (2008)

Article Oncology

Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis

D Braithwaite et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)

Article Medicine, General & Internal

Statistics Notes - Interaction revisited: the difference between two estimates

DG Altman et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)